CA2677043A1 - Method for distinguishing between lung squamous carcinoma and other non small cell lung cancers - Google Patents

Method for distinguishing between lung squamous carcinoma and other non small cell lung cancers Download PDF

Info

Publication number
CA2677043A1
CA2677043A1 CA002677043A CA2677043A CA2677043A1 CA 2677043 A1 CA2677043 A1 CA 2677043A1 CA 002677043 A CA002677043 A CA 002677043A CA 2677043 A CA2677043 A CA 2677043A CA 2677043 A1 CA2677043 A1 CA 2677043A1
Authority
CA
Canada
Prior art keywords
nucleic acid
sequence
lung
mirna
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002677043A
Other languages
English (en)
French (fr)
Inventor
Ranit Aharonov
Nitzan Rosenfeld
Shai Rosenwald
Hila Benjamin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rosetta Genomics Ltd
Original Assignee
Rosetta Genomics Ltd.
Ranit Aharonov
Nitzan Rosenfeld
Shai Rosenwald
Hila Benjamin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rosetta Genomics Ltd., Ranit Aharonov, Nitzan Rosenfeld, Shai Rosenwald, Hila Benjamin filed Critical Rosetta Genomics Ltd.
Publication of CA2677043A1 publication Critical patent/CA2677043A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6841In situ hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002677043A 2007-03-01 2008-02-28 Method for distinguishing between lung squamous carcinoma and other non small cell lung cancers Abandoned CA2677043A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US90417107P 2007-03-01 2007-03-01
US60/904,171 2007-03-01
US2134608P 2008-01-16 2008-01-16
US61/021,346 2008-01-16
PCT/IL2008/000261 WO2008104985A2 (en) 2007-03-01 2008-02-28 Methods for distingushing between lung squamous carcinoma and other non smallcell lung cancers

Publications (1)

Publication Number Publication Date
CA2677043A1 true CA2677043A1 (en) 2008-09-04

Family

ID=39616499

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002677043A Abandoned CA2677043A1 (en) 2007-03-01 2008-02-28 Method for distinguishing between lung squamous carcinoma and other non small cell lung cancers

Country Status (5)

Country Link
EP (1) EP2126116A2 (ja)
JP (1) JP2010519899A (ja)
AU (1) AU2008220449A1 (ja)
CA (1) CA2677043A1 (ja)
WO (1) WO2008104985A2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101475984A (zh) * 2008-12-15 2009-07-08 江苏命码生物科技有限公司 一种非小细胞肺癌检测标记物及其检测方法、相关生物芯片和试剂盒
WO2010070637A2 (en) * 2008-12-15 2010-06-24 Rosetta Genomics Ltd. Method for distinguishing between adrenal tumors
WO2010103522A1 (en) * 2009-03-10 2010-09-16 Rosetta Genomics Ltd. Method for detection of nucleic acid sequences
WO2010120853A2 (en) * 2009-04-16 2010-10-21 Padma Arunachalam Methods and compositions to detect and differentiate small rnas in rna maturation pathway
EP2691545B1 (en) * 2011-03-28 2017-06-14 Rosetta Genomics Ltd Methods for lung cancer classification
AU2017277647B2 (en) 2016-06-08 2023-07-27 President And Fellows Of Harvard College Engineered viral vector reduces induction of inflammatory and immune responses
CN111511918A (zh) 2017-11-08 2020-08-07 哈佛学院院长及董事 抑制病毒载体诱导的炎症反应的组合物和方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2554818A1 (en) * 2004-02-09 2005-08-25 Thomas Jefferson University Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
WO2007148235A2 (en) * 2006-05-04 2007-12-27 Rosetta Genomics Ltd Cancer-related nucleic acids

Also Published As

Publication number Publication date
EP2126116A2 (en) 2009-12-02
WO2008104985A2 (en) 2008-09-04
JP2010519899A (ja) 2010-06-10
AU2008220449A1 (en) 2008-09-04
WO2008104985A3 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
US9133522B2 (en) Compositions and methods for the diagnosis and prognosis of mesothelioma
US20150099665A1 (en) Methods for distinguishing between specific types of lung cancers
WO2010018563A2 (en) Compositions and methods for the prognosis of lymphoma
EP2691545B1 (en) Methods for lung cancer classification
WO2007148235A2 (en) Cancer-related nucleic acids
US20160115546A1 (en) Micrornas expression signature for determination of tumors origin
CA2677043A1 (en) Method for distinguishing between lung squamous carcinoma and other non small cell lung cancers
US9834821B2 (en) Diagnosis and prognosis of various types of cancers
WO2010004562A2 (en) Methods and compositions for detecting colorectal cancer
WO2011024157A1 (en) Nucleic acid sequences related to cancer
WO2011030334A1 (en) Compositions and methods for treatment, diagnosis and prognosis of mesothelioma
WO2009066291A2 (en) Micrornas expression signature for determination of tumors origin
EP2294218A2 (en) Compositions and methods for diagnosis, prognosis and treatment of mesothelioma
US8563252B2 (en) Methods for distinguishing between lung squamous carcinoma and other non small cell lung cancers
WO2010058393A2 (en) Compositions and methods for the prognosis of colon cancer
WO2010103522A1 (en) Method for detection of nucleic acid sequences
WO2010018564A1 (en) Compositions and methods for determining the prognosis of bladder urothelial cancer
WO2010070637A2 (en) Method for distinguishing between adrenal tumors
US20130123138A1 (en) Compositions and methods for prognosis of mesothelioma
WO2011039757A2 (en) Compositions and methods for prognosis of renal cancer
WO2010016064A2 (en) Gene expression signature for classification of kidney tumors

Legal Events

Date Code Title Description
FZDE Discontinued